Deborah Brauer, MD
Internal Medicine · Alexandria, VANPI 1700031481
Payments from drug & device makers
Across 214 payments — averaging $16.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$374
- Pfizer$262
- Takeda Pharmaceuticals U.S.A., Inc.$261
- Ferring Pharmaceuticals Inc.$244
- Johnson & Johnson$191
- plus $865 from 20 others
What the payments were for
- Consulting fees$110%
- Food & beverage$3,55599%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 100 | $1,391 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $374 |
| Pfizer | 14 | $262 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $261 |
| Ferring Pharmaceuticals Inc. | 14 | $244 |
| Johnson & Johnson | 8 | $191 |
| UCB, Inc. | 8 | $166 |
| Sanofi | 4 | $73 |
| Romark Laboratories, LC | 3 | $73 |
| Bristol Myers Squibb | 3 | $54 |
| Intercept Pharmaceuticals, Inc. | 3 | $54 |
| Gilead | 3 | $53 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Medtronic | 1 | $41 |
| Braintree Laboratories, Inc. | 2 | $36 |
| Madrigal Pharmaceuticals | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| Redhill Biopharma Inc. | 2 | $33 |
| Stryker | 1 | $33 |
| Ironwood Pharmaceuticals, Inc | 1 | $21 |
| Celltrion USA Inc. | 1 | $21 |
| Novo Nordisk | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Ardelyx, Inc. | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Alfasigma USA, Inc. | 1 | $15 |
How this compares
$3,588 in reported general payments places this provider in the 85th percentile of 2,724 internal medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 11 | $607 |
| Pantoprazole Sodium | 41 | $502 |
| Omeprazole | 18 | $137 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Alexandria
- Habib ChotaniAlexandria$504K
- Jorge RamalloAlexandria$34K
- Leroy VaughanRichmond$20.8M
- James ClarkCharlottesville$16.2M
- Nabil AndrawisBurke$8.5M
- Mary BlumbergNorfolk$6.5M
- David RamstadSuffolk$5.8M
- Andrew PoklepovicRichmond$4.6M
- Nashwa GabraBurke$4.3M
- Michael DevittCharlottesville$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.